Conditioned mesenchymal stem cells attenuate progression of chronic kidney disease through inhibition of epithelial-to-mesenchymal transition and immune modulation. [electronic resource]
Producer: 20140211Description: 2935-49 p. digitalISSN:- 1582-4934
- Animals
- Apoptosis
- Ascorbic Acid -- analogs & derivatives
- CD4-Positive T-Lymphocytes -- immunology
- Cells, Cultured
- Coculture Techniques
- Creatinine -- metabolism
- Disease Progression
- Epidermal Growth Factor -- metabolism
- Epithelial-Mesenchymal Transition
- Female
- Fibroblast Growth Factor 2 -- metabolism
- Fibronectins -- biosynthesis
- Fibrosis
- Glomerulosclerosis, Focal Segmental
- Hepatocyte Growth Factor -- metabolism
- Humans
- Kidney -- cytology
- Kidney Tubules, Proximal -- cytology
- Lymphocyte Count
- Male
- Mesenchymal Stem Cell Transplantation
- Mesenchymal Stem Cells -- metabolism
- Microfilament Proteins -- deficiency
- Middle Aged
- Nephrectomy
- Podocytes -- cytology
- Rats
- Rats, Sprague-Dawley
- Renal Insufficiency, Chronic -- metabolism
- Transforming Growth Factor beta1 -- metabolism
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.